U.S. trial tests ivonescimab for advanced biliary tract cancer
A National Cancer Institute-funded phase 2/3 trial will test ivonescimab plus chemotherapy against standard chemoimmunotherapy in U.S. patients with advanced ...
A National Cancer Institute-funded phase 2/3 trial will test ivonescimab plus chemotherapy against standard chemoimmunotherapy in U.S. patients with advanced ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine